319 related articles for article (PubMed ID: 11996323)
21. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
22. Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration.
Rosenbaum DP; Petersen JS; Ducharme S; Markham P; Goldberg DI
J Pharm Sci; 1997 May; 86(5):591-5. PubMed ID: 9145384
[TBL] [Abstract][Full Text] [Related]
23. Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis.
Shibata M; Shimokawa Y; Sasahara K; Yoda N; Sasabe H; Suzuki M; Umehara K
Biopharm Drug Dispos; 2017 May; 38(4):301-312. PubMed ID: 28092695
[TBL] [Abstract][Full Text] [Related]
24. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
26. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
29. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats].
Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T
Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.
Pérez LY; Menéndez R; Más R; González RM
Curr Ther Res Clin Exp; 2006 Nov; 67(6):406-19. PubMed ID: 24678113
[TBL] [Abstract][Full Text] [Related]
31. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
[TBL] [Abstract][Full Text] [Related]
32. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats.
Penninks AH; Hilgers L; Seinen W
Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046
[TBL] [Abstract][Full Text] [Related]
33. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
34. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics and tissue distribution of ipecac syrup].
Yamashita M; Yamashita M; Fujii Y
Chudoku Kenkyu; 2001 Jan; 14(1):11-5. PubMed ID: 11381462
[No Abstract] [Full Text] [Related]
36. Distribution in skin of ceramide after oral administration to rats.
Ueda O; Hasegawa M; Kitamura S
Drug Metab Pharmacokinet; 2009; 24(2):180-4. PubMed ID: 19430175
[TBL] [Abstract][Full Text] [Related]
37. [Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
Jpn J Antibiot; 1986 Apr; 39(4):979-90. PubMed ID: 3761551
[TBL] [Abstract][Full Text] [Related]
38. Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.
Khetarpal VK; Markham PM; Ziemniak JA
Drug Metab Dispos; 1994; 22(2):216-23. PubMed ID: 8013277
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
[TBL] [Abstract][Full Text] [Related]
40. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
